High-dose, short-term corticosteroids for ARDS caused by COVID-19 : a case series
© 2020 The Authors. Respirology Case Reports published by John Wiley & Sons Australia, Ltd on behalf of The Asian Pacific Society of Respirology..
We report a case series of seven mechanically ventilated patients with acute respiratory distress syndrome (ARDS) caused by coronavirus disease (COVID-19) who received early treatment with high-dose, short-term systemic corticosteroids to prevent cytokine overproduction. Of the seven patients, four were male and median age was 69 years. They were intubated within seven days after admission when their respiratory status rapidly worsened. At that time, we administered 1000 or 500 mg/day for three days of methylprednisolone intravenously, followed by 1 mg/kg and tapered off. The median duration for the total administration of corticosteroids was 13 days. This high-dose, short-term corticosteroid therapy enabled extubation of the patients within seven days. Many questions on the clinical management of COVID-19 remain unanswered, and data on corticosteroid therapy as a choice of treatment are mixed. We present the clinical course of our cases, review the previous evidence, and discuss management.
| Errataetall: |
CommentIn: Adv Respir Med. 2021;89(5):550-551. - PMID 34612506 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:8 |
|---|---|
| Enthalten in: |
Respirology case reports - 8(2020), 6 vom: 03. Aug., Seite e00596 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
So, Clara [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
ARDS |
|---|
| Anmerkungen: |
Date Revised 03.11.2021 published: Electronic-eCollection CommentIn: Adv Respir Med. 2021;89(5):550-551. - PMID 34612506 Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1002/rcr2.596 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM310938015 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM310938015 | ||
| 003 | DE-627 | ||
| 005 | 20231225141155.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/rcr2.596 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1036.xml |
| 035 | |a (DE-627)NLM310938015 | ||
| 035 | |a (NLM)32514354 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a So, Clara |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a High-dose, short-term corticosteroids for ARDS caused by COVID-19 |b a case series |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 03.11.2021 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a CommentIn: Adv Respir Med. 2021;89(5):550-551. - PMID 34612506 | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2020 The Authors. Respirology Case Reports published by John Wiley & Sons Australia, Ltd on behalf of The Asian Pacific Society of Respirology. | ||
| 520 | |a We report a case series of seven mechanically ventilated patients with acute respiratory distress syndrome (ARDS) caused by coronavirus disease (COVID-19) who received early treatment with high-dose, short-term systemic corticosteroids to prevent cytokine overproduction. Of the seven patients, four were male and median age was 69 years. They were intubated within seven days after admission when their respiratory status rapidly worsened. At that time, we administered 1000 or 500 mg/day for three days of methylprednisolone intravenously, followed by 1 mg/kg and tapered off. The median duration for the total administration of corticosteroids was 13 days. This high-dose, short-term corticosteroid therapy enabled extubation of the patients within seven days. Many questions on the clinical management of COVID-19 remain unanswered, and data on corticosteroid therapy as a choice of treatment are mixed. We present the clinical course of our cases, review the previous evidence, and discuss management | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a ARDS | |
| 650 | 4 | |a COVID‐19 | |
| 650 | 4 | |a corticosteroid therapy | |
| 650 | 4 | |a mechanical ventilation | |
| 700 | 1 | |a Ro, Shosei |e verfasserin |4 aut | |
| 700 | 1 | |a Murakami, Manabu |e verfasserin |4 aut | |
| 700 | 1 | |a Imai, Ryosuke |e verfasserin |4 aut | |
| 700 | 1 | |a Jinta, Torahiko |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Respirology case reports |d 2013 |g 8(2020), 6 vom: 03. Aug., Seite e00596 |w (DE-627)NLM244269440 |x 2051-3380 |7 nnns |
| 773 | 1 | 8 | |g volume:8 |g year:2020 |g number:6 |g day:03 |g month:08 |g pages:e00596 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/rcr2.596 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 8 |j 2020 |e 6 |b 03 |c 08 |h e00596 | ||